March 13, 2026
1 min read

FDA fires off another manufacturing-related CRL, this one to Hyloris

The FDA has rejected Hyloris Pharmaceuticals’ antiviral valacyclovir, an oral suspension for infections caused by herpes simplex and varicella-zoster viruses becasue of manufacturing problems.

Leave a Reply

Your email address will not be published.

Previous Story

Nutrition

Next Story

FDA scolds CDMO Simtra with warning letter over contamination fumbles

Previous Story

Nutrition

Next Story

FDA scolds CDMO Simtra with warning letter over contamination fumbles

Latest from Blog

ROFI Drives New Approach to Crop Nutrition

With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader
Go toTop